This research trial studies Yttrium Y 90 resin microspheres in collecting data from patients
with liver cancer not capable of being removed by surgery (unresectable) for the
radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable
(RESIN) liver tumor registry. The information generated will help doctors better understand
treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes
for patients, as well as guide future research for using Y90 therapy, especially for those
conditions where data is currently very limited or lacking.
- Patients who have selected Y90 therapy for the first time.
- Provision of written informed consent.
- Age 18 and older.
- Patients who are being re-treated with Y90, even if new areas are being targeted. If
patients have received Y90 treatment as part of their first and ongoing round of Y90
therapy, they are eligible to participate.